Phenytoin Infatabs (PHENYTOIN)
Phenytoin Infatabs (PHENYTOIN) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Phenytoin Infatabs; Generic name: PHENYTOIN; Drug class: Anti-epileptic Agent [EPC].
| Brand name | Phenytoin Infatabs |
|---|---|
| Generic name | PHENYTOIN |
| Drug class | Anti-epileptic Agent [EPC] |
| Manufacturer | NCS HealthCare of KY, LLC dba Vangard Labs |
| Used for | 1 INDICATIONS AND USAGE Phenytoin Infatabs are indicated for the treatment of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. Phenytoin Infatabs are indicated for the treatment of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION NOT FOR ONCE-A-DAY DOSING ( 2.1 ) Adult starting dose in patients who have received no previous treatment is two Infatabs three times a day, with dose adjustments as necessary. For most adults, the satisfactory maintenance dose will be six to eight Infatabs daily; an increase to twelve Infatabs daily may be made, if necessary. ( 2.2 ) Pediatric starting dose is 5 mg/kg/day in two to three equally divided doses, with dosage adjustments as necessary, up to a maximum of |
| Active ingredient(s) | PHENYTOIN |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0d240b2b-bc5c-4989-a20b-54ed37a09a4f |